Cargando…

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study

BACKGROUND: Older age and frailty are risk factors for poor clinical outcomes following SARS-CoV-2 infection. As such, COVID-19 vaccination has been prioritised for individuals with these factors, but there is concern that immune responses might be impaired due to age-related immune dysregulation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tut, Gokhan, Lancaster, Tara, Sylla, Panagiota, Butler, Megan S, Kaur, Nayandeep, Spalkova, Eliska, Bentley, Christopher, Amin, Umayr, Jadir, Azar, Hulme, Samuel, Ayodele, Morenike, Bone, David, Tut, Elif, Bruton, Rachel, Krutikov, Maria, Giddings, Rebecca, Shrotri, Madhumita, Azmi, Borscha, Fuller, Christopher, Baynton, Verity, Irwin-Singer, Aidan, Hayward, Andrew, Copas, Andrew, Shallcross, Laura, Moss, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252532/ https://www.ncbi.nlm.nih.gov/pubmed/35813280 http://dx.doi.org/10.1016/S2666-7568(22)00118-0

Ejemplares similares

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
por: Tut, Gokhan, et al.
Publicado: (2021)

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
por: Tut, Gokhan, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
por: Stirrup, Oliver, et al.
Publicado: (2022)

Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
por: Tut, Gokhan, et al.
Publicado: (2022)

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
por: Krutikov, Maria, et al.
Publicado: (2022)

Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study
por: Shrotri, Madhumita, et al.
Publicado: (2022)

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
por: Giddings, Rebecca, et al.
Publicado: (2021)

Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
por: Krutikov, Maria, et al.
Publicado: (2022)

Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)
por: Stirrup, Oliver, et al.
Publicado: (2022)

Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study
por: Stirrup, Oliver, et al.
Publicado: (2023)

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
por: Shrotri, Madhumita, et al.
Publicado: (2021)

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
por: Krutikov, Maria, et al.
Publicado: (2021)

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
por: Parry, Helen, et al.
Publicado: (2022)

Investment, Q and epidemic diseases
por: Tut, Daniel
Publicado: (2022)

FinTech and the COVID-19 pandemic: Evidence from electronic payment systems
por: Tut, Daniel
Publicado: (2023)

Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England
por: Krutikov, Maria, et al.
Publicado: (2021)

Assessment of Factors Affecting Fish Production and Marketing in Gambella Region, Ethiopia
por: Deng, Gatriay Tut
Publicado: (2020)

The importance of long-term well management in geothermal power systems using fuzzy control: A Western Anatolia (Turkey) case study
por: Tut Haklıdır, Füsun S.
Publicado: (2020)

Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI)
por: Krutikov, Maria, et al.
Publicado: (2021)

Feeding Preference and Habitat Association of Defassa Waterbuck (Kobus ellipsiprymnus defassa) in Nechisar National Park, Southern Ethiopia
por: Deng, Gatriay Tut, et al.
Publicado: (2021)

Face Mask Use and Associated Factors Among Students: Mixed Methods Study
por: Addis Gesese, Abreha, et al.
Publicado: (2023)

Measuring microtubule dynamics
por: Zwetsloot, Alexander James, et al.
Publicado: (2018)

Molecular Assay Development to Monitor the Kinetics of Viable Populations of Two Biocontrol Agents, Bacillus subtilis QST 713 and Gliocladium catenulatum J1446, in the Phyllosphere of Lettuce Leaves
por: Tut, Gurkan, et al.
Publicado: (2021)

Radiotherapy Response in Microsatellite Instability Related Rectal Cancer
por: Shin, Joo-Shik, et al.
Publicado: (2013)

Areca use among adolescents in Yap and Pohnpei, the Federated States of Micronesia
por: Milgrom, Peter, et al.
Publicado: (2013)

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
por: Dowell, Alexander C., et al.
Publicado: (2021)

Efficacy evaluation of an anti-caries varnish: protocol for a phase II randomised controlled trial
por: Milgrom, Peter, et al.
Publicado: (2017)

Proposing a Practical, Simplified Framework for Implementing Integrated Diabetes Data and Technology Solutions
por: Espinoza, Juan C., et al.
Publicado: (2022)

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
por: Parry, Helen, et al.
Publicado: (2021)

Keeping track of the SARS-CoV-2 vaccine pipeline
por: Parker, Edward P. K., et al.
Publicado: (2020)

Perceptions of palliative care in a South Asian community: findings from an observational study
por: Dosani, Naheed, et al.
Publicado: (2020)

Integrating REDCap patient-reported outcomes with the HealtheIntent population health platform: proof of concept
por: Espinoza, Juan, et al.
Publicado: (2023)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
por: Dowell, Alexander C., et al.
Publicado: (2022)

Gene promoter polymorphism of RUNX2 and risk of osteoporosis in postmenopausal Indonesian women
por: Auerkari, Elza I, et al.
Publicado: (2014)

An interactive website tracking COVID-19 vaccine development
por: Shrotri, Madhumita, et al.
Publicado: (2021)

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67
por: Tut, V M, et al.
Publicado: (2001)

Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis
por: Parry, Helen, et al.
Publicado: (2021)

Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey
por: Shallcross, Laura, et al.
Publicado: (2021)

Epidemiological description of a protracted cholera outbreak in Tonj East and Tonj North counties, former Warrap State, South Sudan, May-Oct 2017
por: Nsubuga, Fred, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_81pr92piq070ann14in11bq7c5